Healthcare provider profile · identity verified

Andre Critsinelis, MD

Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · BOSTON, MA · NPI 1689136590

Profile state: payments only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Andre Critsinelis, MD received $8,046.33 in general payments during 2025 across 126 reported records.

W. L. Gore & Associates, Inc. accounted for 33.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 40 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$8,046.33

126 reported records · 19 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported companyCanonical companyAmountShareRecordsYear
W. L. Gore & Associates, Inc. Unresolved — no canonical attribution shown $2,675.2033.2%402025
Bolton Medical Inc Unresolved — no canonical attribution shown $1,243.9415.5%192025
Endologix LLC Unresolved — no canonical attribution shown $791.119.8%92025
Medtronic, Inc. Medtronic, Inc.
exact · evidence 2025-07-22
$694.568.6%92025
Penumbra, Inc. Unresolved — no canonical attribution shown $499.196.2%52025
Boston Scientific Corporation Unresolved — no canonical attribution shown $331.424.1%102025
PolyNovo North America LLC Unresolved — no canonical attribution shown $331.164.1%22025
Shockwave Medical, Inc Unresolved — no canonical attribution shown $322.864.0%52025
Cook Medical LLC Unresolved — no canonical attribution shown $262.833.3%82025
Artivion, Inc. Unresolved — no canonical attribution shown $195.142.4%12025
Terumo Medical Corporation Unresolved — no canonical attribution shown $186.592.3%62025
InspireMD Ltd Unresolved — no canonical attribution shown $141.571.8%12025
CVRx, Inc. Unresolved — no canonical attribution shown $127.531.6%42025
Imperative Care, Inc Unresolved — no canonical attribution shown $67.390.8%12025
Abbott Laboratories Unresolved — no canonical attribution shown $47.760.6%22025
Stryker Corporation Unresolved — no canonical attribution shown $37.350.5%12025
Acera Surgical, Inc. Unresolved — no canonical attribution shown $36.090.5%12025
Reflow Medical Inc Unresolved — no canonical attribution shown $34.290.4%12025
LeMaitre Vascular, Inc. Unresolved — no canonical attribution shown $20.350.2%12025

What were the payments for?

Payment categories

CategoryAmountRecords
Food and Beverage$7,221.02121
Education$747.044
Travel and Lodging$78.271

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported productTypeReported companyRelated amount*RecordsYear
GORE TAG Conformable Thoracic Endoprosthesis
Normalized: gore tag conformable thoracic endoprosthesis
Device W. L. Gore & Associates, Inc. $805.97 11 2025
Source payment records
TREO ABDOMINAL STENT-GRAFT SYSTEM
Normalized: treo abdominal stent graft system
Device Bolton Medical Inc $792.39 13 2025
Source payment records
EXCLUDER Conformable AAA Endoprosthesis with Active Control
Normalized: excluder conformable aaa endoprosthesis with active control
Device W. L. Gore & Associates, Inc. $620.11 8 2025
Source payment records
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis
Normalized: gore excluder thoracoabdominal branch endoprosthesis
Device W. L. Gore & Associates, Inc. $462.98 8 2025
Source payment records
GORE VIABAHN VBX Balloon Expandable Endo
Normalized: gore viabahn vbx balloon expandable endo
Device W. L. Gore & Associates, Inc. $361.38 6 2025
Source payment records
RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM
Normalized: relay thoracic stent graft with plus delivery system
Device Bolton Medical Inc $350.03 6 2025
Source payment records
NOVOSORB BTM
Normalized: novosorb btm
Device PolyNovo North America LLC $331.16 2 2025
Source payment records
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter
Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter
Device Shockwave Medical, Inc $322.86 5 2025
Source payment records
ENDURANT IIS
Normalized: endurant iis
Device Medtronic, Inc. $235.53 4 2025
Source payment records
GORE VIABAHN Endoprosthesis with Heparin
Normalized: gore viabahn endoprosthesis with heparin
Device W. L. Gore & Associates, Inc. $218.26 2 2025
Source payment records
Alto Abdominal Stent Graft System
Normalized: alto abdominal stent graft system
Device Endologix LLC $213.66 3 2025
Source payment records
BIOGLUE SURGICAL ADHESIVE
Normalized: bioglue surgical adhesive
Device Artivion, Inc. $195.14 1 2025
Source payment records
PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM
Normalized: photofix decellularized bovine pericardium
Device Artivion, Inc. $195.14 1 2025
Source payment records
Vascular
Normalized: vascular
Device Artivion, Inc. $195.14 1 2025
Source payment records
Penumbra System
Normalized: penumbra system
Device Penumbra, Inc. $183.11 2 2025
Source payment records
Indigo System
Normalized: indigo system
Device Penumbra, Inc. $172.75 2 2025
Source payment records
GELWEAVE
Normalized: gelweave
Device Bolton Medical Inc $155.18 1 2025
Source payment records
AZUR CX DETACHABLE
Normalized: azur cx detachable
Device Terumo Medical Corporation $150.25 4 2025
Source payment records
General - Vascular Intervention
Normalized: general vascular intervention
Device Boston Scientific Corporation $149.63 1 2025
Source payment records
RUBY Coil
Normalized: ruby coil
Device Penumbra, Inc. $143.33 1 2025
Source payment records
GORE TAG Thoracic Branch Endoprosthesis
Normalized: gore tag thoracic branch endoprosthesis
Device W. L. Gore & Associates, Inc. $142.45 3 2025
Source payment records
CGuard Prime Carotid Stent System
Normalized: cguard prime carotid stent system
Device InspireMD Ltd $141.57 1 2025
Source payment records
Barostim Neo System
Normalized: barostim neo system
Device CVRx, Inc. $127.53 4 2025
Source payment records
HAWKONE
Normalized: hawkone
Device Medtronic, Inc. $123.76 1 2025
Source payment records
ZILVER PTX
Normalized: zilver ptx
Device Cook Medical LLC $105.16 3 2025
Source payment records
ZENITH
Normalized: zenith
Device Cook Medical LLC $97.48 4 2025
Source payment records
ENROUTE Transcarotid Neuroprotection System
Normalized: enroute transcarotid neuroprotection system
Device Boston Scientific Corporation $73.19 4 2025
Source payment records
SYMPHONY CATHETER
Normalized: symphony catheter
Device Imperative Care, Inc $67.39 1 2025
Source payment records
GLIDESHEATH SLENDER
Normalized: glidesheath slender
Device Terumo Medical Corporation $65.42 3 2025
Source payment records
ZENITH SPIRAL-Z
Normalized: zenith spiral z
Device Cook Medical LLC $60.19 1 2025
Source payment records
ABRE
Normalized: abre
Device Medtronic, Inc. $55.48 2 2025
Source payment records
ESPRIT
Normalized: esprit
Device Abbott Laboratories $47.76 2 2025
Source payment records
GORE EXCLUDER AAA Endoprosthesis
Normalized: gore excluder aaa endoprosthesis
Device W. L. Gore & Associates, Inc. $45.65 1 2025
Source payment records
EkoSonic
Normalized: ekosonic
Device Boston Scientific Corporation $44.79 1 2025
Source payment records
LIMFLOW SYSTEM
Normalized: limflow system
Device Stryker Corporation $37.35 1 2025
Source payment records
Restrata Wound Matrix
Normalized: restrata wound matrix
Device Acera Surgical, Inc. $36.09 1 2025
Source payment records
ENROUTE Transcarotid Stent
Normalized: enroute transcarotid stent
Device Boston Scientific Corporation $33.31 3 2025
Source payment records
ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter
Normalized: enroute enflate transcarotid rx balloon dilatation catheter
Device Boston Scientific Corporation $30.50 1 2025
Source payment records
ARTEGRAFT VASCULAR GRAFT
Normalized: artegraft vascular graft
Device LeMaitre Vascular, Inc. $20.35 1 2025
Source payment records
GORE VIABAHN Endoprosthesis
Normalized: gore viabahn endoprosthesis
Device W. L. Gore & Associates, Inc. $18.40 1 2025
Source payment records

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

YearGeneral PaymentsMain payerExplicit productsCompany overlapsPart D coverage
2025 $8,046.33 · 126 records W. L. Gore & Associates, Inc. ABRE, ARTEGRAFT VASCULAR GRAFT, AZUR CX DETACHABLE, Alto Abdominal Stent Graft System, BIOGLUE SURGICAL ADHESIVE, Barostim Neo System, CGuard Prime Carotid Stent System, ENDURANT IIS, ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter, ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent, ESPRIT, EXCLUDER Conformable AAA Endoprosthesis with Active Control, EkoSonic, GELWEAVE, GLIDESHEATH SLENDER, GORE EXCLUDER AAA Endoprosthesis, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE TAG Conformable Thoracic Endoprosthesis, GORE TAG Thoracic Branch Endoprosthesis, GORE VIABAHN Endoprosthesis, GORE VIABAHN Endoprosthesis with Heparin, GORE VIABAHN VBX Balloon Expandable Endo, General - Vascular Intervention, HAWKONE, Indigo System, LIMFLOW SYSTEM, NOVOSORB BTM, PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM, Penumbra System, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, RUBY Coil, Restrata Wound Matrix, SYMPHONY CATHETER, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, TREO ABDOMINAL STENT-GRAFT SYSTEM, Vascular, ZENITH, ZENITH SPIRAL-Z, ZILVER PTX
2024 Complete

Questions to ask

Questions you could discuss with your doctor

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Loaded source releases

DatasetYearPublicationSource
CMS Open Payments — General Payments 2025 2026-06-30 Original source
Medicare Part D Prescribers by Provider and Drug 2024 2026-05-06 Original source
NPPES Data Dissemination V2 current / reference data 2026-08-10 Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error